SCHEMBL21396832

SCHEMBL21396832

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)cc(-c2cccc(-n3c4cnccc4c4ccncc43)c2)cc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.34
DYRK1A Q13627 2/20 0.34
PIP4K2A P48426 5/20 0.33
CDK4 P11802 1/20 0.32
CDK6 Q00534 1/20 0.32
CYP11B1 P15538 2/20 0.32
GSK3B P49841 1/20 0.32
KCNH2 Q12809 1/20 0.32
MAOA P21397 1/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HIF1A Q16665 1/20 0.32
DHODH Q02127 1/20 0.31
PDE10A Q9Y233 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397076 0.98 CYP11B2 (0.38) CYP11B2DYRK1APIP4K2ACDK4CDK6
SCHEMBL21396880 0.98 CYP11B2 (0.38) CYP11B2DYRK1APIP4K2ACDK4CDK6
SCHEMBL21396875 0.94 CYP11B2 (0.36) CYP11B2DYRK1APIP4K2ACDK4CDK6
SCHEMBL21396825 0.92 CYP11B2 (0.38) CYP11B2DYRK1AMAOAKDM4EDHODH
SCHEMBL21396874 0.92 CYP11B2 (0.39) CYP11B2DYRK1APIP4K2ACDK4CDK6
SCHEMBL21378046 0.88 CYP11B2 (0.39) CYP11B2PIP4K2ACYP11B1MAOAKDM4E
SCHEMBL15945750 0.86 ATM (0.41) DYRK1ACDK4CDK6GSK3BKCNH2
SCHEMBL21378021 0.86 CYP11B2 (0.38) CYP11B2CDK4CDK6CYP11B1MAOA
SCHEMBL21481249 0.85 ATM (0.44) DYRK1ACDK4CDK6GSK3BKCNH2
SCHEMBL15945601 0.85 ATM (0.44) DYRK1ACDK4CDK6GSK3BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885DYRK1A 4722/4885PIP4K2A 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.